Proanthocyanidin B2 Alleviates Cuprizone‐Induced Demyelination by Regulating the Astrocytic xCT/GSH/GPX4 Axis
CNS Neuroscience & Therapeutics · 2025-09 · 31 (9)
DOI: 10.1111/cns.70598 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 18.09.2025. Verfasst von Jian Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Neurobiology, the Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of Stat…. Hauptthemen laut MEDLINE: Proanthocyanidins, Demyelinating Diseases, Astrocytes, Amino Acid Transport System y+. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Youth Science Foundation Project, Research Funding Project for Returned Overseas Students in Shanxi Province, Traditional Chinese Medicine Innovation Team of Shanxi Provincial Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Background
Multiple sclerosis (MS) is marked by inflammatory demyelination in the central nervous system (CNS), involving diverse glial populations. This pathological process is associated with inflammation and oxidative stress. Proanthocyanidin B2 (PCB2), with its potent antioxidant properties, has been shown to alleviate demyelination in the cuprizone (CPZ) mouse model. It attenuates neuroinflammation and oxidative stress in both the cerebral microenvironment and astrocytes (AS). The xCT/GSH/GPX4 axis is a key regulatory pathway for oxidative stress. Therefore, we hypothesize that PCB2 can alleviate CPZ‐induced demyelination by regulating the xCT/GSH/GPX4 axis in AS.
Methods
The study utilized forty C57BL/6 mice, randomly allocated into four groups of ten: a control group, a control group supplemented with PCB2 (60 mg/kg/day), a CPZ‐exposed group, and a CPZ‐exposed group supplemented with PCB2 (60 mg/kg/day). The control groups received a standard diet, whereas the CPZ groups were given the same diet supplemented with 0.2% CPZ for 6 weeks. From the fifth week onwards, the control and CPZ groups were administered physiological saline via intraperitoneal injection, whereas the PCB2‐supplemented groups received PCB2 for 2 weeks. Immunofluorescence staining, Western blot, and ELISA elucidated the cellular/molecular mechanisms of PCB2 targeting the xCT/GSH/GPX4 axis in AS to alleviate demyelination in vivo and in vitro.
Results
In this study, PCB2 markedly regulated the xCT/GSH/GPX4 axis in AS, ameliorated the behavioral performance in CPZ mice, reduced inflammation, oxidative stress, lipid peroxidation, and the damage to oligodendrocytes (OLs), and inhibited demyelination.
Conclusion
PCB2 can regulate the entire xCT/GSH/GPX4 axis of AS to reduce CPZ‐induced OL injury and demyelination, which may be a potentially effective drug for the treatment of multiple sclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Neurobiology, the Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine, Shanxi University of…
- Caidian District People's Hospital, Wuhan, Hubei, China.
ORCID-Profile: Jian Liu, Cun-Gen Ma
Förderung
- National Youth Science Foundation Project
- Research Funding Project for Returned Overseas Students in Shanxi Province
- Traditional Chinese Medicine Innovation Team of Shanxi Provincial Administration of Traditional Chinese Medicine
- Basic Research Project of Shanxi Province
- Medical Science and Technology Leading Team of Shanxi Provincial Health Commission
- Research Project of Shanxi Provincial Administration of Traditional Chinese Medicine
- Project Proposal for Traditional Chinese Medicine Research by Shanxi Provincial Health Commission in 2022
- Discipline Construction Fund of Shanxi University of Chinese Medicine
Zitieren
APA
Liu, J., Hou, Y. X., Chen, Y., Liang, Y. J., Pu, M., Zheng, L. L., Zhang, Z. W., Xiao, Y., Mao, Z., Ma, C. G., & Wang, Q. (2025). Proanthocyanidin B2 Alleviates Cuprizone‐Induced Demyelination by Regulating the Astrocytic xCT/GSH/GPX4 Axis. CNS Neuroscience & Therapeutics, 31(9). https://doi.org/10.1111/cns.70598
Vancouver
Liu J, Hou YX, Chen Y, Liang YJ, Pu M, Zheng LL, et al. Proanthocyanidin B2 Alleviates Cuprizone‐Induced Demyelination by Regulating the Astrocytic xCT/GSH/GPX4 Axis. CNS Neuroscience & Therapeutics. 2025;31(9). doi:10.1111/cns.70598
BibTeX
@article{Liu2025,
author = {Liu, Jian and Hou, Yan-Xia and Chen, Ying and Liang, Ya-Jie and Pu, Meng and Zheng, Lu-Lu and Zhang, Zi-Wei and Xiao, Ying and Mao, Zhen and Ma, Cun-Gen and Wang, Qing},
title = {Proanthocyanidin B2 Alleviates Cuprizone‐Induced Demyelination by Regulating the Astrocytic xCT/GSH/GPX4 Axis},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {9},
doi = {10.1111/cns.70598}
}
EUVIMED